Amgen (NASDAQ: AMGN) and Kyowa Kirin Co., Ltd. (TSE: 4151) reported preliminary results from the ASCEND study evaluating rocatinlimab, an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE